Zacks Investment Research
22 Oct 2026, 16:26 UTC · 1h ago
Philip Morris Reports Q3 Earnings: ETFs in Focus
Impact · against what's priced in
Philip Morris provides strong evidence for the acceleration of reduced-risk products that the market has previously declined to value. The upgrade in volume growth forecasts and the surge in E-Vapor shipments directly address the core uncertainty regarding the company's ability to hit its required long-term revenue CAGR.
- PM+0.50
Challenges what's priced in
- The price assumes
The acceleration of reduced-risk product revenue beyond the current 15% growth pace
The market is not currently paying for accelerated growth in reduced-risk products, but the reported 61.6% year-over-year surge in E-Vapor shipments and the upgrade to growing total volumes for 2026 provide concrete evidence that this acceleration is occurring.
What PM's price assumes · Sep 1
Top 1 mover · tap to explore
